Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Drug Giant Roche Buys Former Google Execs' Flatiron in $1.9B Deal

  • Post author:Sam
  • Post published:February 15, 2018
  • Post category:BioPharma

Roche will plunk down $1.9M to acquire Flatiron Health, which has previously been backed by GV, as well as Roche. Source: BioSpace

Continue ReadingDrug Giant Roche Buys Former Google Execs' Flatiron in $1.9B Deal

Why Novavax Could be a Millionaire-Maker Stock

  • Post author:Sam
  • Post published:February 15, 2018
  • Post category:BioPharma

If you had a crystal ball, you probably would have invested in Berkshire Hathaway in 1964, or Apple in the 1980s. Source: BioSpace

Continue ReadingWhy Novavax Could be a Millionaire-Maker Stock

Russia Allegedly Behind Merck's Cyberattack Last Year

  • Post author:Sam
  • Post published:February 15, 2018
  • Post category:BioPharma

Government officials say they are now certain they know who launched the NotPetya cyberwar that slammed operations at Merck last year. Source: BioSpace

Continue ReadingRussia Allegedly Behind Merck's Cyberattack Last Year

FDA Advisory Panel Spurns Pacira's Request for Expanded Use of Pain Drug Exparel

  • Post author:Sam
  • Post published:February 15, 2018
  • Post category:BioPharma

Shares of Pacira plunged more than 15 percent this morning after the company revealed the FDA panel's decision. Source: BioSpace

Continue ReadingFDA Advisory Panel Spurns Pacira's Request for Expanded Use of Pain Drug Exparel

Amag Investors Cheer as Biotech Wins Second Drug Approval This Month

  • Post author:Sam
  • Post published:February 15, 2018
  • Post category:BioPharma

Makena was approved by the FDA in February 2011 and remains the first and only FDA-approved treatment option currently available for pregnant women who have had a prior spontaneous preterm…

Continue ReadingAmag Investors Cheer as Biotech Wins Second Drug Approval This Month

Illumina Leaves Mission Bay for New Campus in the Peninsula

  • Post author:Sam
  • Post published:February 15, 2018
  • Post category:BioPharma

The new campus will consolidate some 400 employees in one place and give more space to the startup companies it helps. Source: BioSpace

Continue ReadingIllumina Leaves Mission Bay for New Campus in the Peninsula

Superstar Investors Jump in on Celgene Spinout Celularity's $250M Funding Round

  • Post author:Sam
  • Post published:February 15, 2018
  • Post category:BioPharma

Celularity is a biotech founded by stem cell pioneer Robert Hariri, MD, PhD. Source: BioSpace

Continue ReadingSuperstar Investors Jump in on Celgene Spinout Celularity's $250M Funding Round

Teva Surges After Warren Buffett's Berkshire Reports $358M Stake

  • Post author:Sam
  • Post published:February 14, 2018
  • Post category:BioPharma

Teva got a nice shot in the arm after reports that billionaire investor Warren Buffett took a stake in the company. Source: BioSpace

Continue ReadingTeva Surges After Warren Buffett's Berkshire Reports $358M Stake

J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer

  • Post author:Sam
  • Post published:February 14, 2018
  • Post category:BioPharma

Janssen got a little love from the FDA on Wednesday. Source: BioSpace

Continue ReadingJ&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer

Vertex Nixes Three Planned Phase III CF Trials in France

  • Post author:Sam
  • Post published:February 14, 2018
  • Post category:BioPharma

Vertex has declined to comment, but BioCentury received a copy of the letter the company sent to laboratories explaining. Source: BioSpace

Continue ReadingVertex Nixes Three Planned Phase III CF Trials in France
  • Go to the previous page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.